1. The survival time of patients with plasmacytic myeloma;Osgood;Cancer Chemother Rep,1960
2. Mouse myeloma;Bergsagel,1975
3. Plasma cell myeloma: response of melphalan-resistant patients to high-dose intermittent cyclophsophamide;Bergsagel;Can Med Assoc J,1972
4. Phase III study of intermittent carmustine (BCNU), cyclophsophamide, and prednisone versus melphalan and prednisone in multiple myeloma;Abramson;Cancer Treat Rep,1982
5. An update of two randomized trials in previously untreated multiple myeloma comparing melphalan-prednisone versus three and five drug combinations: a GATLA study;Pavlovksy;J. Clin Oncol,1988